AD
Exendin-3(CAS: 130357-25-4)
CAS Number
Related Products
![1-[4-Chloro-6-(methylsulfanyl)-5-pyrimidinyl]methanamine](https://static.chemtradehub.com/structs/885/885269-49-8-e182.webp)
4,5-Pyrimidinediamine
CAS Number: 13754-19-3
2-Bromotriphenylene
CAS Number: 19111-87-6
![N-(6-Ethylthieno[2,3-d]pyrimidin-4-yl)glycine](https://static.chemtradehub.com/structs/313/313534-29-1-ef9e.webp)
Ethyl 5-bromo-2,4-diethoxybenzoate
CAS Number: 1131587-93-3
Other Suppliers for Exendin-3
Basic Information
Molecular Formula
C184H282N50O61S
Molecular Weight
4202.57 g/mol
Chemical Identifiers
SMILES
[H]/N=C(\N)NCCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)CC
InChIKey
LMHMJYMCGJNXRS-IEQINRSDSA-N
Database References
MDL Number
MFCD00240170
FAQ
Exendin-3 (CAS: 130357-25-4) is subject to regulatory guidelines such as the REACH regulations in the EU, which require registration, evaluation, authorization, and restriction of chemicals. In the USA, it falls under the jurisdiction of FDA and EPA for pharmaceutical and environmental safety standards. GHS classification is also applicable, categorizing it based on its physical and health hazards.
Alternatives to Exendin-3 in synthesis include other GLP-1 receptor agonists like exenatide and liraglutide. These can be synthesized using similar methods, with slight modifications. Common alternative reagents include various amino acids and their derivatives, which can be used as building blocks in peptide synthesis.
The market for Exendin-3 (CAS: 130357-25-4) is driven by increasing interest in diabetes and weight management therapies. Research trends focus on its potential as a therapeutic agent, with ongoing studies on its efficacy and safety. Market dynamics include rising demand from pharmaceutical companies and academic institutions for further exploration of its medicinal applications.
Waste containing Exendin-3 (CAS: 130357-25-4) should be collected in appropriate containers and stored in a secure, labeled area. Incineration is a common method for disposal, followed by professional waste disposal services if necessary. Environmental protection precautions include ensuring no leakage into the environment and complying with local regulations regarding hazardous waste management.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
sales@haoreagent.com
Mobile
15813841136
Telephone
0755-89459231
Fax
0755-89459231
Visit Website
https://www.haoreagent.com/